Professor John Campbell is Director of Tissues, Cells and Advanced Therapeutics at the Scottish National Blood Transfusion Service (SNBTS) in Edinburgh. He completed his PhD in Pathology at Edinburgh in 1995, and has worked in the cellular therapy field for more than 30 years across the academic, biotechnology and healthcare sectors. He is currently the national head of research for SNBTS and holds academic appointments at the Universities of Glasgow and Edinburgh. He is also a co-founder of Resolution Therapeutics Ltd. Whilst working in industry, he was heavily involved in development of reagents and equipment to drive the manufacture and characterization of cellular therapeutics. SNBTS has a substantial cellular therapy research and manufacturing programme, with over 90 full time staff working on basic cellular function; translation of laboratory protocols to full GMP processes; and manufacturing of tissue and cellular therapeutics. SNBTS has a two fully MHRA licensed, GMP cellular therapy production centres at the Scottish Centre for Regenerative Medicine and the Jack Copland Centre, Edinburgh. SNBTS has a strong focus on the development and translation of novel autologous and allogeneic cellular therapies for first in man clinical use and over 20 years’ experience in the use of T lymphocytes to treat cancer and viral disease in immune-suppressed patients.